ciprofloxacina aurobindo 250 mg
apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 250mg - chinolone antibacteriene fluorochinolone
ciprofloxacina aurobindo 500 mg
apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 500mg - chinolone antibacteriene fluorochinolone
ciprofloxacina aurobindo 750 mg
apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 750mg - chinolone antibacteriene fluorochinolone
ciprofloxacina aurobindo 250 mg
apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 250mg - chinolone antibacteriene fluorochinolone
ciprofloxacina aurobindo 500 mg
apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 500mg - chinolone antibacteriene fluorochinolone
ciprofloxacina aurobindo 750 mg
apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 750mg - chinolone antibacteriene fluorochinolone
heplisav b
dynavax gmbh - hepatita b antigen de suprafață - hepatita b - vaccinuri - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
prehevbri
vbi vaccines b.v. - hepatita b antigen de suprafață - hepatita b - vaccinuri - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.